Table 4.
Baseline | Post-Tx | Baseline | Post-Tx | |||
---|---|---|---|---|---|---|
Study | 25(OH)D | 25(OH)D | 25(OH)D | 25(OH)D | ||
Year | Group | N | Mean | Mean | Range ** | Range ** |
1996 | UVB + Placebo | 7 | 37.9 | 96.1 | 20 to 80 | 45 to 159 |
UVB + Calcitirol | 6 | 27.3 | 67.1 | 15 to 40 | 45 to 123 | |
2010 | UVB | 29 | 23 * | 51 * | 9 to 46 | 32 to 112 |
No UVB | 29 | 12 * | 13 * | 7 to 42 | 7 to 33 | |
2009 | BB-UVB | 26 | 38 ± 17 | 69 ± 20 | 17 to 82 | 45 to 118 |
NB-UVB | 42 | 35 ± 12 | 55 ± 18 | 15 to 73 | 28 to 98 | |
2010 | BB-UVB | 24 | 37 ± 17 | 60 ± 19 | 18 to 88 | 25 to 90 |
Sunshine | 20 | 23 ± 6 | 42 ± 6 | 18 to 42 | 30 to 60 | |
Total | 183 |
Note: N = number of patients, * = median, ** = range estimated from figure in manuscript.